Saratoga Research & Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-4,525
| Closed | -$438K | – | 43 |
|
|
2017
Q4 | $438K | Hold |
4,525
| – | – | 0.03% | 35 |
|
|
2017
Q3 | $402K | Sell |
4,525
-540
| -11% | -$48K | 0.03% | 34 |
|
|
2017
Q2 | $367K | Sell |
5,065
-205
| -4% | -$14.9K | 0.03% | 36 |
|
|
2017
Q1 | $343K | Sell |
5,270
-180
| -3% | -$11.7K | 0.03% | 37 |
|
|
2016
Q4 | $341K | Sell |
5,450
-160
| -3% | -$10K | 0.03% | 36 |
|
|
2016
Q3 | $354K | Sell |
5,610
-340
| -6% | -$21.5K | 0.03% | 35 |
|
|
2016
Q2 | $368K | Hold |
5,950
| – | – | 0.03% | 38 |
|
|
2016
Q1 | $340K | Hold |
5,950
| – | – | 0.03% | 41 |
|
|
2015
Q4 | $352K | Sell |
5,950
-1,210
| -17% | -$71.6K | 0.03% | 40 |
|
|
2015
Q3 | $390K | Sell |
7,160
-164,556
| -96% | -$8.96M | 0.04% | 39 |
|
|
2015
Q2 | $11.5M | Sell |
171,716
-18,971
| -10% | -$1.27M | 1.1% | 31 |
|
|
2015
Q1 | $11.2M | Sell |
190,687
-10,256
| -5% | -$600K | 1.04% | 31 |
|
|
2014
Q4 | $13.2M | Sell |
200,943
-7,912
| -4% | -$518K | 1.22% | 28 |
|
|
2014
Q3 | $12.1M | Sell |
208,855
-25,732
| -11% | -$1.49M | 1.19% | 29 |
|
|
2014
Q2 | $13.2M | Sell |
234,587
-12,439
| -5% | -$702K | 1.32% | 29 |
|
|
2014
Q1 | $12.7M | Sell |
247,026
-7,960
| -3% | -$409K | 1.29% | 30 |
|
|
2013
Q4 | $13.5M | Sell |
254,986
-4,092
| -2% | -$216K | 1.43% | 28 |
|
|
2013
Q3 | $11.6M | Sell |
259,078
-27,404
| -10% | -$1.23M | 1.36% | 28 |
|
|
2013
Q2 | $11.8M | Buy |
+286,482
| New | +$11.8M | 1.39% | 28 |
|